- Home
- PED vs MAIA Comparison
PED vs MAIA Comparison
Compare PED & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- MAIA
- Stock Information
- Founded
- PED N/A
- MAIA 2018
- Country
- PED United States
- MAIA United States
- Employees
- PED N/A
- MAIA N/A
- Industry
- PED Oil & Gas Production
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- MAIA Health Care
- Exchange
- PED Nasdaq
- MAIA Nasdaq
- Market Cap
- PED 54.5M
- MAIA 56.3M
- IPO Year
- PED N/A
- MAIA 2022
- Fundamental
- Price
- PED $0.60
- MAIA $1.54
- Analyst Decision
- PED Strong Buy
- MAIA
- Analyst Count
- PED 1
- MAIA 0
- Target Price
- PED $1.50
- MAIA N/A
- AVG Volume (30 Days)
- PED 141.0K
- MAIA 469.2K
- Earning Date
- PED 11-13-2025
- MAIA 11-11-2025
- Dividend Yield
- PED N/A
- MAIA N/A
- EPS Growth
- PED 569.41
- MAIA N/A
- EPS
- PED 0.14
- MAIA N/A
- Revenue
- PED $35,334,000.00
- MAIA N/A
- Revenue This Year
- PED N/A
- MAIA N/A
- Revenue Next Year
- PED $17.41
- MAIA N/A
- P/E Ratio
- PED $4.29
- MAIA N/A
- Revenue Growth
- PED 3.93
- MAIA N/A
- 52 Week Low
- PED $0.47
- MAIA $1.40
- 52 Week High
- PED $1.04
- MAIA $3.48
- Technical
- Relative Strength Index (RSI)
- PED 48.45
- MAIA 45.86
- Support Level
- PED $0.59
- MAIA $1.54
- Resistance Level
- PED $0.62
- MAIA $1.78
- Average True Range (ATR)
- PED 0.03
- MAIA 0.09
- MACD
- PED 0.00
- MAIA 0.01
- Stochastic Oscillator
- PED 28.70
- MAIA 25.00
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.